Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Hangzhou Tigermed Consulting Co's Revenue for the
three
months ended in Mar. 2026 was €226.1 Mil. Hangzhou Tigermed Consulting Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was €170.6 Mil.
Hence, Hangzhou Tigermed Consulting Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.33.
Hangzhou Tigermed Consulting Co (FRA:5HZ1) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Hangzhou Tigermed Consulting Co Receivables Turnover Related Terms
Hangzhou Tigermed Consulting Co Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Tigermed Consulting Co Receivables Turnover Chart
FRA:5HZ1 vs TMO, DHR, IDXX: Receivables Turnover Comparison
For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Tigermed Consulting Co Receivables Turnover vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Hangzhou Tigermed Consulting Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Tigermed Consulting Co (FRA:5HZ1) has a Receivables Turnover of 1.33 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Hangzhou Tigermed Consulting Co and its competitors. According to the industry distribution chart, Hangzhou Tigermed Consulting Co ranks #103 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 51%.
Is Hangzhou Tigermed Consulting Co's Receivables Turnover too high?
Hangzhou Tigermed Consulting Co's current Receivables Turnover is 1.33. The Medical Diagnostics & Research industry median Receivables Turnover is 5.38. Hangzhou Tigermed Consulting Co's value of 1.33 is 75.3% below this industry median. Based on the distribution chart, Hangzhou Tigermed Consulting Co ranks #103 out of 202 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Hangzhou Tigermed Consulting Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Tigermed Consulting Co's Receivables Turnover compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Hangzhou Tigermed Consulting Co ranks #103 out of 202 companies for Receivables Turnover. This places Hangzhou Tigermed Consulting Co in the lower half of its industry. The industry median Receivables Turnover is 5.38. Hangzhou Tigermed Consulting Co's value of 1.33 is 75.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Diagnostics & Research company?
The median Receivables Turnover among Medical Diagnostics & Research companies is 5.38, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou Tigermed Consulting Co's current Receivables Turnover of 1.33 is 75.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Hangzhou Tigermed Consulting Co and its competitors. For the Medical Diagnostics & Research industry, the median Receivables Turnover is 5.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Tigermed Consulting Co's current Receivables Turnover is 1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Tigermed Consulting Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co (FRA:5HZ1) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.72, compared to a current price of €4.06 — trading 14% below its estimated fair value. The current Receivables Turnover is 1.33 and 75.3% below the Medical Diagnostics & Research industry median of 5.38. Hangzhou Tigermed Consulting Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Hangzhou Tigermed Consulting Co (FRA:5HZ1), the current Receivables Turnover is 1.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou Tigermed Consulting Co (FRA:5HZ1) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued.
The current stock price of €4.06 is trading 14% below its estimated GF Value™ of €4.72.
GuruFocus considers Hangzhou Tigermed Consulting Co to be Modestly Undervalued.
Key valuation signals for FRA:5HZ1:
Receivables Turnover: 1.33
GF Value™: €4.72 vs. price of €4.06 (14% below fair value)
Industry Position: 75.3% below the Medical Diagnostics & Research median (#103 of 202)
No single metric tells the full story. See the FRA:5HZ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
87GF Score
Get the complete analysis for FRA:5HZ1
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5HZ1 has been successfully added to your 
